Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease

REFERENCES

• PETTY TL: Definitions in chronic obstructive pulmonary disease. Clio. Chest Med. (1990) 11(3):363–373.
   PubMed Web of Science ®Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987. Am. Rev Respir: Dis. (1987) 136(1):225–244.
   Google Scholar
• PAUWELS RA, BUIST AS, CALVERLEY PM, JENKINS CR, HURD SS; THE GOLD SCIENTIFIC COMMITTEE: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. I Respir: Crit. Care. Med. (2001) 163(5):1256–1276.
   Google Scholar
• MACKAY DN: Treatment of acute bronchitis in adults without underlying lung disease. J. Gen. Intern. Med. (1996) 11(9):557–562.
   PubMed Web of Science ®Google Scholar
• BURROWS B, BLOOM JW, TRAVER GA, CLINE MG: The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl. I Med (1987) 317(21):1309–1314.
   PubMed Web of Science ®Google Scholar
• ORR PH, SCHERER K, MACDONALD A, MOFFAT ME: Randomised placebo- controlled trials of antibiotic for acute bronchitis: A critical review of the literature. Fam. Pract. (1993) 36(5):507–512.
   Google Scholar
• CHODOSH S: Treatment of acute exacerbations of chronic bronchitis: state of the art. Arn. J. Med. (1991) 91(6A):87–92.
   Google Scholar
• CHODOSH S: Examination of sputum cells. N Engl. J. Med (1970) 282(15):854–857.
   PubMed Web of Science ®Google Scholar
• LEBARGY F, LE ROY LADURIE F, LENORMAND E, PARIENTE R: Intraepithelial T-lymphocyte subsets in the airways of normal subjects and/or patients with chronic bronchitis. Am. Rev. Respir: Dis. (1989) 140(3):737–742.
   PubMedGoogle Scholar
• SAETTA M, DI STEFANO A, MAESTRELLI P et al.: Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir: Dis. (1993) 147(2):301–306.
   PubMed Web of Science ®Google Scholar
• DUNNILL MS, MASSARELLA GR, ANDERSON JA: A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax (1969) 24(2):176–179.
   PubMed Web of Science ®Google Scholar
• GUMP DW, PHILLIPS CA, FORSYTH BR, MCINTOSH K, LAMBORN KR, STOUCH WH: Role of infection in chronic bronchitis. Am. Rev Respir. Dis (1976) 113(4):465–474.
   PubMed Web of Science ®Google Scholar
• EADIE MB, STOTT EJ, GRIST NR: Virological studies in chronic bronchitis. Br. Med. (1966) 2:671.
   PubMed Web of Science ®Google Scholar
• LAMY ME, POUTHIER-SIMON F, DEBACKER-WILLAME E: Respiratory viral infections in hospital patients with chronic bronchitis. Chest (1973) 63(3):336–341.
   PubMed Web of Science ®Google Scholar
• MeNAMARA MJ, PHILLIPS IA, WILLIAMS OB: Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am. Rev Respir. Dis. (1969) 100(1):19–24.
   PubMedGoogle Scholar
• HOGG JC: Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Arn Respir Crit Care Med. (2001) 164(10, Part 2):71–75.
   Google Scholar
• BUSCHO RO, SAXTAN D, SHULTZ PS, FINCH E, MUFSON MA: Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J. Infect. Dis. (1978) 137(4):377–383.
   PubMed Web of Science ®Google Scholar
• GREENBERG SB: Viral respiratory infections in elderly patients and patients with chronic obstructive pulmonary disease. Am. J. Med. (2002) 112 (Suppl. 6A):28–32.
   Google Scholar
• KARNAK D, BENGISUN JS, BEDER S, KAYACAN 0: Chlamydia pneumonia infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir. Med. (2001) 95(10):811–816.
   PubMed Web of Science ®Google Scholar
• BJERKESTRAND G, DIGRANES A, SCHREINER A: Bacteriological findings in transtracheal aspirates from patients with chronic bronchitis and bronchiectasis. Scand. Respir. Dis. (1975) 56(4):201–207.
   PubMedGoogle Scholar
• BARTLETT JG: Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am. Rev Respir: Dis (1977) 115 (5) :777–782.
   PubMed Web of Science ®Google Scholar
• MOGULKOC N, KARAKURT S, ISALSKA B et al.: Acute prulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am. J. Respir: Crit. Care. Med. (1999) 160:349–353.
   PubMed Web of Science ®Google Scholar
• LAURILLA AL, VON-HERTZEN L, SAIKKU P: Chlamydia pneumoniae and chronic lung diseases. Scand. J. Infect. Dis. (1997) 104(Suppl.):34–36.
   Google Scholar
• SOLER N, TORRES A, EWIG S et al.: Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am. I Respir: Crit. Care. Med. (1998) 157(5. Part 1):1498–1505.
   Google Scholar
• VON-HERTZEN L, ISOAHO R, LEINONEN M et al.: Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int. J. Epidemiol (1996) 25(3):658–664.
   PubMed Web of Science ®Google Scholar
• VON-HERTZEN L, TOYRYLA M, GIMISHANOV A et al.: Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Chit. Exp. Allergy (1998) 29(4):522–528.
   Web of Science ®Google Scholar
• BLAST F, LEGNANI D, LOMBARDO VM et al.: Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur: Respir: J. (1993) 6(1):19–22.
   PubMed Web of Science ®Google Scholar
• BEATY CD, GRAYSTON JT, WANG SP, KUO CC, RETO CS, MARTIN TR: Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am. Rev Respir. Dis. (1991) 144(6):1408–1410.
   PubMedGoogle Scholar
• BEN-YAAKOV M, ESHEL G, ZAKSONSKI L, LAZAROVICH Z, BOLDUR I: Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection. J. Chit. Pathol (2002) 55(5):355–358.
   PubMed Web of Science ®Google Scholar
• BLAST F, TARSIA P, AROSIO C, FAGETTI L, ALLEGRA L: Epidemiology of Chlamydia pneumoniae. Chit. Microbial. Infect. (1998) 4 (Suppl. 4):1–6.
   Google Scholar
• MIYASHITA N, FUKANO H, YOSHIDA K, NIKI Y, MATSUSHIMA T: Seroepidemiology of of Chlamydia pneumoniae in Japan between 1991 and 2000.1 Clin. Pathol (2002) 55(2):115–117.
   Google Scholar
• HAHN DL, AZENABOR AA, BEATTY WL, BYME GI: Chlamydia pneumoniae as a respiratory pathogen. Front. Biosci. (2002) 7:66–76.
   PubMed Web of Science ®Google Scholar
• HJELM E, WESSLEN L, GNARPE E et al.: Antibodies to Chlamydia pneumoniae in young Swedish orienteers. Scand. I Infect. Dis. (2001) 33(8):589–592.
   PubMedGoogle Scholar
• MIYASHITA N, NIKI Y, NAKAJIMA M, FUKANO H, MATSUSHIMA T: Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest (2001) 119(5):1416–1419.
   PubMed Web of Science ®Google Scholar
• DOWELL SF, PEELING RW, BOMAN J et al.: Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. (2001) 33(4):492–503.
   PubMed Web of Science ®Google Scholar
• JONES RB: Introduction to Chlamydialdiseases. In: Principles and Practice of Infectious Diseases, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, New York, USA (1995):1676–1685.
   Google Scholar
• EMRE U, ROBLIN PM, GELLING M et al.: The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Merl (1994) 148(7):727–732.
   PubMed Web of Science ®Google Scholar
• EMRE U, SOKOLOVSKAYA N, ROBLIN PM et al.: Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J. Infect. Dis. (1995) 172(1):265–267.
   PubMed Web of Science ®Google Scholar
• HAMMERSCLAG MR: Chlamydia pneumoniae and the lung. Eur Respir (2000) 16(5):1001–1007.
   PubMed Web of Science ®Google Scholar
• JACKSON LA, GRAYSTON JT: Chlamydia pneumoniae. In: Principles and Practice of Infectious Diseases Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia, USA (2000):2007–2012.
   Google Scholar
• BOURKE SJ, LIGHTFOOT NF: Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis. Thorax (1995) 50\(Suppl. 1):43–48
   Google Scholar
• MIYASHITA N, NIKI Y, NAKAJIMA M, KAWANE H, MATSUSHIMA T: Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest (1998) 114(4):969–971.
   PubMed Web of Science ®Google Scholar
• GUTIREREZ J, MEND OZA J, FERNANDEZ F, LINARES-PALOMINO J, SOTO M, MAROTO MC: ELISA test to detect Chlamydophila pneumoniae IgG. Basic Microbic] (2002) 42(1):13–18.
   PubMed Web of Science ®Google Scholar
• GAYDOS CA, ROBLIN PM, HAMMERS CHLAG MR et al.: Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of C. pneumoniae in symptomatic and asymptomatic patients. I Clin. Microbiol (1994) 32(4):903–905.
   Google Scholar
• SAINT S, BENT S, VITTINGHOFF E, GRADDY D: Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA. (1995) 273(12):957–960.
   PubMed Web of Science ®Google Scholar
• FUCHS PC, BARRY AL, BROWN SD: Prevalence of resistance to three fluoroquinolones: Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group. Antimicrob. Agents. Chemother. (1996) 40(7):1633–1639.
   PubMed Web of Science ®Google Scholar
• CABELLO H, TORRES A, CELIS R et al: Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur. Respic J. (1997) 10(5):1137–1144.
   PubMed Web of Science ®Google Scholar
• FAGON JY, CHASTRE J: Severe exacerbations of COPD patients: the role of pulmonary infections. Semin. Respic Infect. (1996) 11(2):109–118.
   PubMedGoogle Scholar
• VERGIS EN, INDORF A, FILE TM et al.: Azithromycin versus cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalised patients: A prospective, randomised, multicenter trial. Arch. Intern. Med. (2000) 160(9):1294–1300.
   PubMedGoogle Scholar
• KLEIN NC, CUNHA BA:Tetracyclines. Med. Clin. North. Am. (1995) 79(4):789–801.
   PubMed Web of Science ®Google Scholar
• SCHNAPPINGER D, HILLEN W: Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch. Microbiol (1996) 165(6):359–369.
   PubMed Web of Science ®Google Scholar
• JOSHI N, MILLER DQ: Doxycycline revisited. Arch. Intern. Med. (1997) 157(13):1421–1428
   PubMedGoogle Scholar
• STANDIFORD HC: Tetracyclines and chloramphenicol. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds.), Churchill Livingstone, New York, USA (1995):306–310.
   Google Scholar
• AMSDEN GW: Erythromycin, Clarithromycin, and Azithromycin: Are the Differences Real. Clin. Then (1996) 18(1):56–72.
   PubMed Web of Science ®Google Scholar
• CHU SY, WILSON DS, GUAY DR, CRAFT C: Clarithromycin pharmacokinetics in healthy young and elderly volunteers." Clin. Pharmacy]. (1992) 32(11):1045–1049.
   Google Scholar
• DARK D: Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. Am. J. Med. (1991) 91(3A):315–355.
   Google Scholar
• AMSDEN GW. Advanced-generation macrolides: tissue-directed antibiotics. mt. Antimicrob. Agents (2001) 18\(Suppl. 1):S11–S15.
   Google Scholar
• DRLICA K, ZHAO X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbial Mal Biol. Rev (1997) 61(3):377–392.
   PubMed Web of Science ®Google Scholar
• FILE TM JR, SEGRETI J, DUNBAR L et al.: A multicenter, randomised study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents. Chemothet (1997) 41(9):1965–1972.
   PubMed Web of Science ®Google Scholar
• RAMIREZ JA, NGUYEN TH, TEILLIER G et al.: A prospective, randomised, double-blind, comparative study treating community-acquired pneumonia with once-daily gatifloxacin versus twice-daily clarithromycin. Resp. Dis. (1999) 20(11, Suppl.):40–45.
   Google Scholar
• FINCH R, SCHURMANN D, COLLINS 0, KUBIN R et al.: Randomised controlled trial of sequential intravenous (iv.) and oral moxifloxacin compared with sequential iv. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob. Agents Chemother. (2002) 46(6):1746–1754
   Google Scholar
• SAINTS, FLAHERTY KR, ABRAHAMSE P, MARTINEZ FJ, FENDRICK AM: Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy. Clin. Ther. (2001) 23(3):499–512.
   PubMed Web of Science ®Google Scholar
• HAHN DL: Treatment of Chlamydia pneumoniae infection in adult asthma: A before-after trial." Fam. Pract. (1995) 41(4):345–351.
   Google Scholar
• MUHLESTEIN JB, ANDERSON JL, HAMMOND EH et al.: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azitromycin prevents it in rabbit model. Circulation. (1998) 97(7):633–636.
   PubMed Web of Science ®Google Scholar